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The aim of the present studywas to evaluate antioxidant, antimicrobial, anti-HIV, and cholinesterase inhibitory activities of aqueous
and alcoholic extracts from leaves, stems, and flowers of Euphorbia characias. The extracts showed a high antioxidant activity
and were a good source of total polyphenols and flavonoids. Ethanolic extracts from leaves and flowers displayed the highest
inhibitory activity against acetylcholinesterase and butyrylcholinesterase, showing potential properties against Alzheimer’s disease.
Antimicrobial assay showed that leaves and flowers extracts were active against all Gram-positive bacteria tested. The ethanolic
leaves extract appeared to have the strongest antibacterial activity against Bacillus cereus with MIC value of 312.5𝜇g/mL followed
by Listeria monocytogenes and Staphylococcus aureus that also exhibited good sensitivity withMIC values of 1250 𝜇g/mL.Moreover,
all the extracts possessed anti-HIV activity.The ethanolic flower extract was themost potent inhibitor ofHIV-1 RTDNApolymerase
RNA-dependent and Ribonuclease H with IC
50
values of 0.26 and 0.33 𝜇g/mL, respectively.The LC-DADmetabolic profile showed
that ethanolic leaves extract contains high levels of quercetin derivatives. This study suggests that Euphorbia characias extracts
represent a good source of natural bioactive compounds which could be useful for pharmaceutical application as well as in food
system for the prevention of the growth of food-borne bacteria and to extend the shelf-life of processed foods.
1. Introduction
There has been a remarkable increment in scientific articles
dealing with research of antioxidant molecules because of
their protective action from the damage induced by oxidative
stress. It causes serious cell and tissue damage leading it to
be the major cause of the pathogenesis of several disease
processes like cancer, diabetes, aging, and cardiovascular
and neurodegenerative diseases. Plant materials represent
a great source of antioxidant and bioactive compounds
which are different in their composition and physical and
chemical properties [1]. Phenolics are broadly distributed in
the plant kingdom and are the most abundant secondary
metabolites of plants. The identification and development
of phenolic compounds or extracts from different plants
has become a major area of health- and medical-related
research. Among these compounds, flavonoids have been
especially highlighted because they have been shown to have
protective roles against many human diseases, due to their
antioxidant capacity, which depends mainly on the number
and position of hydroxyl groups within their structure, and
their anti-inflammatory, anticancer, and antiviral activities
[2]. Their activity as inhibitors of cholinesterase has also
been demonstrated and correlated with their structure and
could be useful for treatment of Alzheimer’s disease (AD)
[3]. AD results from a deficit of cholinergic functions
in the brain. Hence, one of the most promising approaches
for treating this disease is to restore the acetylcholine level
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by inhibiting cholinesterase activity. Acetylcholinesterase
(AChE) and butyrylcholinesterase (BChE) are two cholin-
esterase enzymes that metabolize acetylcholine but differ
in substrate specificity, enzyme kinetics, and activity in
different brain regions. In a healthy brain, AChE is the most
responsible enzyme in regulating acetylcholine levels but, in
patients with AD, AChE activity gradually decreases with the
concomitant increase of BChE. Thus, both AChE and BChE
are legitimate therapeutic targets for treatment of cholinergic
deficit characteristic of AD. Effective therapeutic options for
AD are limited up to now; thus there is a demand for new
natural drugs without side effects.
Moreover, the demand for bioactive compounds from
natural sources as an alternative to synthetic molecules is
continuously increasing also because of the emerging prob-
lem of the multidrug resistance of microorganisms related
to antibiotics and their extensive use. Thus, several studies
related to plant antimicrobials have demonstrated their effi-
cacy towards a large number of pathogens and food-borne
agents causing disease [4–6] as well as viral infections [7–
10]. Although many plant-derived compounds are currently
being used for the treatment of infectious diseases and for the
preservation and extension of the shelf-life of foods, several
medicinal and aromatic plants present worldwide remain still
unexplored.
Euphorbiaceae is a large flowering plant family (300
genera and 8,000 species) widely distributed all around the
world and composed of all sorts of plants (large woody
trees, climbing lianas, or simple weeds) with a wide variety
of chemical substances, many of them with a medicinal
application. Some extracts from Euphorbiaceae plants have
been characterized and patented as modern drugs [11].
Among Euphorbiaceae, the species Euphorbia characias, a
nonsucculent shrub commonly occurring in vast areas of the
Mediterranean region, has been analyzed and several biolog-
ical active compounds were identified [12]. The plant latex
has been the object of several researches and its screening
has revealed the presence of natural rubber and numerous
enzymes some of which interact in a common metabolism
[13–22]. On the other hand, only little attention has been paid
to the other parts of the plant [23–25].
Thus, the objective of this research was to evaluate
antioxidant, antimicrobial, and anticholinesterase properties
of the aqueous and ethanolic extracts of leaves, stems, and
flowers from E. characias in order to find a novel potential
source of bioactivemolecules.Moreover, the antiviral efficacy
of E. characias extracts was also evaluated on the human
immunodeficiency virus type 1 (HIV-1) reverse transcriptase-
(RT-) associated RNA-dependent DNA polymerase (RDDP)
and RibonucleaseH (RNaseH) activities. Both RT-associated
functions are essential for viral replication and are validated
drug targets for which new drugs are still needed [26, 27].
2. Materials and Methods
All chemicals were obtained as pure commercial products
and used without further purification. Acetylcholinesterase
(AChE) from Electrophorus electricus, acetylthiocholine
Figure 1: The Mediterranean shrub Euphorbia characias subsp.
characias.
iodide, 2,2󸀠-azinobis-(3-ethylbenzothiazoline-6-sulfonic
acid) (ABTS), aluminum nitrate, butyrylcholinesterase
(BChE) from equine serum, S-butyrylthiocholine chloride,
3-O-caffeoylquinic acid (chlorogenic acid), catechin, 2,2-
diphenyl-1-picrylhydrazyl radical (DPPH∙), 5,5󸀠-dithiobis(2-
nitrobenzoic acid) (DTNB), ellagic acid, Folin-Ciocalteu
phenol reagent, ferric chloride, galantamine hydrobromide,
gallic acid, 4-hydroxybenzyl alcohol, 6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid (Trolox), myricetin,
2,4,6-tris(2-pyridyl)-1,3,5-triazine (TPTZ), and quercetin
were purchased from Sigma Aldrich (Milan, Italy). LC-MS
grade acetonitrile and formic acid were purchased from
Merck (Darmstadt, Germany). Standards of myricetin-3-
O-glucoside, quercetin-3-O-glucoside, and acacetin were
purchased from Extrasynthese (Genay, France). HPLC
grade water (18MΩ⋅cm) was prepared by using a Millipore
(Bedford, MA, USA) Milli-Q purification system.
Spectrophotometric determinations were obtained with
an Ultrospec 2100 spectrophotometer (Biochrom Ltd., Cam-
bridge, England) using cells with a 1 cm path length.
2.1. Plant Material. E. characias subsp. characias (Figure 1)
was identified by Professor Annalena Cogoni and a voucher
specimen has been deposited in the Department of Sci-
ences of Life and Environment, University of Cagliari, Italy
(number 1216/16 Herbarium CAG). The different parts of E.
characias were collected from February to June, in southern
Sardinia (Dolianova, CA, Italy). The GPS coordinates were
39∘24󸀠19.0󸀠󸀠N and 9∘12󸀠57.6󸀠󸀠E.
Leaves, stems, and flowers were immediately frozen
at −80∘C and then lyophilized in intact condition. The
lyophilized plant materials (1 g) were reduced in powder
and 10mL of water (aqueous extract) or ethanol (ethanol
extract) was added to the dried samples. The extraction was
carried out in the dark at room temperature for 24 h under
continuous stirring. Ethanol extracts were diluted 10-fold
with water in order to freeze and then lyophilize the samples
[24]. Before use, 1mg of dried powders was dissolved in
water or 10%ethanol (1mL), for aqueous and ethanol extracts,
respectively. For antimicrobial and antiviral activity dried
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powderswere dissolved inDMSO (100%) as solvent.The yield
(%, w/w) from all the dried extracts was calculated as follows:
yield (%) = (𝐴1 × 100)/𝐴2, where 𝐴1 is the weight of the
dried extract (after lyophilization) and𝐴2 is the weight of the
plant powder.
2.2. Antioxidant Assays. In every extract total free radi-
cal scavenging molecules were determined by ABTS∙+ and
DPPH∙ methods using Trolox as antioxidant standard, as
previously reported [28, 29]. For both free radical meth-
ods, antioxidant activity was expressed as Trolox equivalent
antioxidant capacity (TEAC; mmol/g dw). The FRAP (ferric
reducing antioxidant power) assay was performed as previ-
ously described [30]. Quantitative analysis was performed
according to the external standard method (FeSO
4
, 0.1–
2mmol/L, 𝑟 = 0.9997) and results were expressed as mmol
Fe2+/g dw.
2.3. Determination of the Total Polyphenols and Flavonoids.
Total content of polyphenols and flavonoids in the extracts
was determined as previously reported [29]. Polyphenol
concentration was calculated using gallic acid as a referred
standard and was expressed as mg of gallic acid (GAE) per 1 g
of dry weight (dw). Flavonoid concentrationwas expressed as
mg of quercetin equivalent (QE) per 1 g of dry extract.
2.4. Acetylcholinesterase and Butyrylcholinesterase Activity.
Acetylcholinesterase from Electrophorus electricus and equine
serum butyrylcholinesterase were used for the inhibitory
assays. AChE activity was measured using Ellman’s reagent
according to the method previously reported [31]. Briefly, the
reaction mixture contained 0.1M phosphate buffer (pH 8.0),
1.5mM 5,5󸀠-dithiobis-2-nitrobenzoate (DTNB), acetylthio-
choline iodide (1.5mM), and extract at the desired con-
centrations or solvent alone (control) in a final volume of
1mL. Finally, enzyme was added to the reaction mixture
and the absorbance immediately monitored at 405 nm. For
butyrylcholinesterase assay, the same procedure was followed
except for the use of enzyme and substrate, which were
BChE and S-butyrylthiocholine, respectively. Galantamine
was used as the standard cholinesterase inhibitor. Results
were expressed as IC
50
values calculated as concentration of
extracts that produces 50% cholinesterase activity inhibition.
2.5. Microbial Strains, Culture Conditions, and Antimicro-
bial Activity. Staphylococcus aureus ATCC 6538, Bacillus
cereus ATCC 11178, Listeria monocytogenes ATCC 19115,
Escherichia coli ATCC 35150 (serotype O157:H7), Salmonella
typhimurium ATCC 14028, Candida albicans ATCC 10231,
Saccharomyces cerevisiae ATCC 2601, Aspergillus flavus
ATCC 46283 (aflatoxin producer), and Penicillium chryso-
genum ATCC 10135 were obtained from the American Type
Culture Collection (ATCC, Rockville, MD, USA) and used
as indicators strains. All bacterial strains were stored on
nutrient broth (NB, Microbiol, Cagliari, Italy) plus 20% (v/v)
glycerol at −20∘C except yeasts and molds strains which were
maintained in potato dextrose broth (Microbiol) with 15%
(v/v) glycerol. Before use, they were subcultured twice in
appropriate medium.
Minimum inhibitory concentrations (MICs) and mini-
mum bactericidal/fungicidal concentrations (MBCs/MFCs)
of the E. characias extracts were determined by a broth
microdilution method [5]. All tests were performed with NB
for bacteria and RPMI 1640 (Sigma, Milan, Italy) buffered
to pH 7.0 with morpholinepropanesulfonic acid (MOPS,
Sigma) for yeasts and molds. The extracts were dissolved in
DMSO (5% v/v). Serial doubling dilutions of each extract
were performed in a 96-well microtiter plate ranging from
19.5 to 5000𝜇g/mL. Overnight broth cultures were prepared
in NB or RPMI and adjusted so that the final concentra-
tion in each well following inoculation was approximately
5.0 × 105 cfu/mL. The concentration of each inoculum was
confirmed using viable counts on Tryptic Soy Agar (TSA,
Microbiol) plates for bacteria, Sabouraud Dextrose Agar
(SDA, Microbiol) for yeasts, and potato dextrose agar (PDA,
Microbiol) for molds. The controls included sterility of NB
and RPMI broths, sterility of the extracts, control culture
(inoculum), and control DMSO to check the effect of solvent
on the growth of microorganisms. Furthermore, gentamicin,
ketoconazole, and amphotericin B were used as positive
controls for bacteria, yeasts, and molds, respectively.
The MICs and MBCs were determined after 24 h incu-
bation of the plates at 37∘C for bacteria and 30∘C for fungi.
Microbial growth was indicated by the presence of turbidity
and a “pellet” on the well bottom. MICs were determined
presumptively as the first well, in ascending order, which
did not produce a pellet. To confirm MICs and to establish
MBCs, 10 𝜇L of broth was removed from each well and
inoculated on TSA, SDA, or PDA plates. After incubation
under the conditions described above, the number of sur-
viving microorganisms was determined. The MIC was the
lowest concentration which resulted in a significant decrease
in inoculum viability (>90%) while the MBC/MFC was the
concentration where 99.9% or more of the initial inoculum
was killed.
All tests were conducted in triplicate and with three
replications, and the modal MIC and MFC values were
selected.
2.6. HIV-1 RT-Associated Functions Biochemical Assays. HIV-
1 RT gene subcloned into the p6HRT prot plasmid was
kindly provided by Stuart LeGrice (NationalCancer Institute,
Frederick, USA). Protein expression and purification was
performed in E. coliM15 strain as described [32]. The HIV-1
RT-associated RDDP and RNase H activity were measured as
previously described [33, 34].
2.7. LC Detection and Quantitative Analysis of
Phenolic Compounds
2.7.1. (HR) LC-ESI-Orbitrap-MS and (HR) LC-ESI-Orbitrap-
MS/MS. The electrospray ionisation (ESI) source of a
Thermo Scientific LTQ-Orbitrap XL (Thermo Scientific,
Germany) mass spectrometer was tuned in negative ion
mode with a standard solution of kaempferol-3-O-glucoside
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Table 1: Yield and antioxidant and antiradical properties of E. characias extracts. DPPH and ABTS values are expressed as mmol TEAC/g
dw; FRAP value is expressed as mmol Fe2+/g dw.
Extracts Yield (w/w%) ABTS DPPH FRAP
Leaves Aqueous 20.4 ± 1.5 2.52 ± 0.18
b 1.8 ± 0.21b 2.70 ± 0.17c
Ethanolic 24.9 ± 2.6 4.68 ± 0.49a 6.73 ± 0.70a 4.57 ± 0.12a
Stems Aqueous 12.3 ± 1.4 0.10 ± 0.01
d 0.17 ± 0.02c 0.89 ± 0.04f
Ethanolic 15.2 ± 1.8 0.85 ± 0.10c 0.88 ± 0.09c 1.36 ± 0.07e
Flowers Aqueous 17.6 ± 2.3 0.62 ± 0.05
cd 0.53 ± 0.05c 1.95 ± 0.02d
Ethanolic 20.6 ± 1.9 0.91 ± 0.10c 0.58 ± 0.05c 3.49 ± 0.09b
Results are expressed as mean ± standard deviation of three independent experiments. Means followed by distinct letters in the same column are significantly
different (𝑝 < 0.05).
(1 𝜇g/mL) infused at a flow rate of 5 𝜇L/min with a syringe
pump. In the FT experiment, resolution of the Orbitrap
mass analyzer was set at 30000. The mass spectrometric
spectra were acquired by full range acquisition covering
𝑚/𝑧 120–1200 in LC-MS. The data recorded were processed
with Xcalibur 2.0 software (Thermo Fisher Scientific). Initial
calibration of the instrument was performed using the stan-
dard LTQ calibration mixture with caffeine and the peptide
MRFA, dissolved in 50 : 50 (v/v) water/acetonitrile solution.
LC/ESI/LIT-Orbitrap-MS was performed using a Finnigan
Surveyor HPLC (Thermo Finnigan, San Jose, CA, USA)
equipped with a Waters (Milford, MA, USA) Xselect CSH
C18 3.5 𝜇m column (150mm × 2.1mm i.d.) and coupled to a
hybrid Linear Ion Trap- (LIT-) Orbitrap mass spectrometer
(Thermo Scientific). Linear gradient elution with a mobile
phase comprising water acidified with 0.1% formic acid
(solvent A) and acetonitrile acidified with 0.1% formic acid
(solvent B) starting from 95% A was converted in 65% A in
45min, from 65% to 0% (A) in 1min, remaining 0% A for 4
minutes, and then from 0% to 95% (A) followed by 10min
of maintenance. The mobile phase was supplied at a flow rate
of 200𝜇L/min keeping the column at room temperature, and
the effluent was injected directly into the ESI source. The
mass spectrometer was operated in negative ion mode. ESI
source parameters were as follows: capillary voltage −12 V;
tube lens voltage −121.47V; capillary temperature 280∘C;
sheath and auxiliary gas flow (N
2
) 30 and 5; sweep gas 0;
and spray voltage 5V. MS spectra were acquired by full range
acquisition covering𝑚/𝑧 120–1600. LC-ESI-LIT-MS/MS data
were obtained by applying a data dependent scan experiment,
by directing to fragmentation the two highest peaks obtained
in LC-ESI-Orbitrap-MS trace. Each parent ion was submitted
to fragmentation with energy of 30% to produce an MS/MS
spectrum in the MS range specific relative to its mass. 1
mg of dried extract obtained from ethanolic extract from E.
characias leaves was dissolved in 10mL of a mixture of water
in acetonitrile and 10 𝜇L was injected in the LC-MS system.
2.7.2. LC-DAD. Detection and quantitative analysis of phe-
nolic compounds were carried out using an HPLC-DAD
method [30]. Chromatograms and spectra were elaborated
with a ChromQuest V. 2.51 data system (ThermoQuest,
Rodano, Milan, Italy). Flavonols were detected and quan-
tified at 360 nm and all the other compounds at 280 nm.
Stock solutions were prepared at 1mg/mL dissolving pure
standards in methanol: water (50 : 50, v/v). The calibration
curves for each compound were calculated by regression
analysis, by plotting the peak area obtained after standards
injection (3 replicates at each concentration) against the
known standard concentrations. The stock solutions were
diluted with methanol in order to obtain work solutions and
the correlation values were 0.9992–0.9998. E. characias leaves
extract was dissolved and injected in the LC-DAD system
with the same condition of the LC-MS analysis.
2.8. Statistical Analysis. Data are reported as mean ± stan-
dard deviation of three independent experiments. The data
were analyzed using one-way analysis of variance (one-way
ANOVA) and Tukey’s posttest. Statistical analysis was per-
formed with GraphPad Prism 7 software (GraphPad Soft-
ware, San Diego, California, USA). A difference was consid-
ered statistically significant at 𝑝 < 0.05.
3. Results and Discussion
3.1. Antioxidant Activity, Polyphenol and Flavonoids Content,
and Cholinesterase Activity Inhibition. Total free radical scav-
enging capacities determined with ABTS and DPPH assays
are reported in Table 1. Comparable TEAC values of each
extract were detected using the two methods. Leaves extracts
exhibited significantly higher free radical scavenging activity
(𝑝 < 0.05) than other extracts, with ethanolic extract showing
the highest activity. Antioxidant activity was also examined
with FRAP assay, confirming that ethanolic extract of leaves
possessed the significantly highest antioxidant activity (𝑝 <
0.05), followed by flower ethanolic extract.
The polyphenol and flavonoid content of the extracts,
expressed as mg of gallic acid or quercetin equivalent,
respectively, are reported in Figure 2. Total phenolic con-
tent varied widely among analyzed parts of the plant and
the highest value was found in leaves in both aqueous
and ethanolic extracts. In fact, the amount of phenolic
compounds in leaves aqueous extract (680mgGAE/g dw)
was about 6- and 2.3-fold higher than the same extract
from stems (102.1mgGAE/g dw) and flowers (289.2mgGAE/
g dw), respectively (Figure 2(a)). Moreover, these results
showed that ethanolic extract of leaves is rich in polyphenols
content (815.7mgGAE/g dw) with a value about 1.5-fold
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Figure 2: Polyphenol and flavonoid content in aqueous (Aq) and ethanolic (Et) leaves, stems, and flowers extracts from E. characias. (a)
Polyphenol amount is expressed as mg of gallic acid equivalent (GAE) per g of dry weight (dw); (b) the amount of flavonoids is expressed as
mg of quercetin equivalent (QE) per g of dry weight (dw). All data are expressed as mean of three measurements ± standard deviation.
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Figure 3: Correlation between phenolic content and antioxidant capacity of E. characias extracts. (a) ABTS assay; (b) DPPH assay. TEAC:
Trolox equivalent antioxidant capacity; GAE: gallic acid equivalents.
higher than the same extract from stems and flowers (about
544.6mgGAE/g dw for each extract). Polyphenols have been
reported to have antioxidant activity mainly based on their
redox properties which have a key role in scavenging free
radicals and chelating oxidant metal ions. High phenolic
content in all E. characias extracts resulted in high TEAC
values determined by ABTS or DPPH methods, which could
indicate that phenolic compounds were capable of function-
ing as free radical scavengers. Good correlation was found
between TEAC values for both ABTS and DPPH (𝑟 = 0.8448
and 𝑟 = 0.7346, resp.) of the different plant extracts and their
phenolic contents (Figure 3), confirming a strong relationship
between antioxidant capacity and phenolic content.
Among phenolic compounds, flavonoids are ubiquitous
plant compounds with an important role as attractants to
pollinators, as sunscreens to protect against UV irradia-
tion, and as antimicrobial and antiherbivory factors [37].
Content of flavonoids is shown in Figure 2(b). Flavonoid
content of flowers ethanolic extract was about 2-fold higher
(241.7mgQE/g dw) than the correspondent extract from the
other part of the plant (∼62mgQE/g dw). This extract also
showed the highest ratio of total flavonoids (TFC) and
phenolic content (TPC) being 0.44, indicating that flavonoids
were almost 40% of the total phenolic content. However,
aqueous extracts of both leaves and stems exhibited the lowest
amounts of total flavonoids (33.2mg and 18.1mgQE/g dw,
resp.), with aqueous extract from leaves showing the lowest
TFC/TPC ratio of 0.05.
Compounds like flavonoids, alkaloids, terpenoids, and
coumarins are known to have the capacity to inhibit
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Table 2: Inhibition of AChE and BChE by E. characias extracts.
Extracts IC50 values (mg/mL)
AChE BChE
Leaves Aqueous 4.2 ± 0.25
c —
Ethanolic 0.6 ± 0.056d 0.39 ± 0.04c
Stems Aqueous 6.9 ± 0.71
a —
Ethanolic 5.8 ± 0.43b —
Flowers Aqueous 5.25 ± 0.35
b 4.2 ± 0.39a
Ethanolic 0.6 ± 0.045d 1.22 ± 0.08b
Galantamine 0.27 ± 0.07 𝜇g/mL 8.12 ± 0.61 𝜇g/mL
Results are expressed as mean ± standard deviation of three independent
experiments. Means followed by distinct letters in the same column are
significantly different (𝑝 < 0.05).
cholinesterase types, key enzymes in the cholinergic nervous
system [38]. This inhibitory activity is usually the first of a
number of requirements for the development of medicines
for treating some neurological disorders such as Alzheimer’s
disease.
Table 2 shows the acetylcholinesterase and butyrylcholin-
esterase inhibitory activities of the E. characias extracts,
compared with those of standard inhibitor galantamine. A
survey on IC
50
values revealed that all the extracts exhibited
acetylcholinesterase inhibitory activity while only few of
them inhibited butyrylcholinesterase. This is not surprising
because AChE and BChE enzymes display distinct substrate
and inhibitor specificities. Most of the other IC
50
values
were about three orders of magnitude higher compared to
the results obtained with galantamine. However, ethanolic
leaves extract showed the significantly highest (𝑝 < 0.05)
butyrylcholinesterase inhibition that is about 50 times less
than the effect of galantamine. This is a good result since the
standard inhibitor is a singlemolecule, whereas plant extracts
are a mixture of numerous compounds and might contain
only few active components.
3.2. Antimicrobial and Anti-HIV Activities. Tables 3(a) and
3(b) report the antagonistic activity of E. characias extracts
against a panel of microorganisms including Gram-negative,
Gram-positive, and spore-forming bacteria, yeast, and mold
species. As can be observed, the leaves extracts appeared to
have the strongest antibacterial activity followed by flow-
ers and stems extracts. Gram-negative bacteria, yeasts, and
molds were the least sensitive, being resistant to all extracts
at the maximum concentration tested (5000𝜇g/mL). Leaves
extracts exhibited antibacterial activity towards all Gram-
positive bacteria tested. B. cereus ATCC 11778 was the most
susceptible strain being totally inhibited by the ethanolic
leaves extract at the concentration of 312.5 𝜇g/mL (MIC
equivalent to MBC). L. monocytogenes ATCC 19115 and S.
aureus ATCC 6538 also exhibited a good sensitivity to the
ethanolic leaves extract as they both showed MIC values
of 1250 𝜇g/mL. Higher MIC values were observed for the
aqueous leaves extracts towards these bacterial strains. As
regards the flowers extracts, all Gram-positive strains tested
were moderately inhibited by both aqueous and ethanolic
extracts withMIC values equal to or greater than 2500𝜇g/mL
with the exception of B. cereus strain which was more
sensitive to the ethanolic extract (MIC 1250 𝜇g/mL). Stems
extracts showed the lowest activity, with ethanolic extract
slightly inhibiting the abovementioned bacterial strains (MIC
5000 𝜇g/mL). Our findings are in agreement with those
reported by Lin et al. for Euphorbia macrorrhiza species
[39], who observed inhibitory activity against S. aureus but
no effect towards E. coli and C. albicans strains tested. In
contrast, Perumal et al. [40] observed antimicrobial effect
for Euphorbia hirta ethanolic extracts towards both Gram-
positive and Gram-negative bacteria with MIC values lower
than those observed in this work. On the other hand, the
antagonistic effect of plants extracts even within the same
species is variable and depends on several factors such as
the concentration of active components due to different
tissue composition, variation in the extraction protocol and
technique used to detect antimicrobial activity, and resistance
of the test microorganisms [41–43].
Finally, E. characias extracts were also tested for their
ability to inhibit the HIV-1 RT-associated RDDP and RNase
H functions using the known nonnucleoside RT inhibitor
efavirenz [27] and the diketo acid derivative RDS1759 [33] as
control for RDDPandRNaseH inhibition, respectively. Inter-
estingly, all extracts were able to inhibit both RT functions
(Table 4). In all cases, ethanolic extractsweremore active than
aqueous extracts and the flower extracts were themost potent
on both enzyme activities.
3.3. LC-ESI-Orbitrap-MS, LC-ESI-Orbitrap-MS/MS, and LC-
DAD Analysis of E. characias Ethanolic Leaves Extract. Con-
sidering all the antioxidants and biological activities of the
extracts, ethanolic extract from leaves appeared to be the
most active extract.Thus, this extract was selected for further
study by liquid chromatography (LC). It was analyzed by
an analytical method developed in LC-ESI-Orbitrap-MS and
LC-ESI-Orbitrap-MS/MS, in negative ionmode.Thenegative
LC-MS profile highlighted the presence of a large group of
compounds corresponding to the deprotonated molecular
ions of different flavonoids and ellagitannin derivatives (Fig-
ure 4). Individual components were identified by comparison
of their 𝑚/𝑧 values in the Total Ion Current (TIC) profile
with those of the selected compounds described in literature
(Table 5). Additional LC-ESI-Orbitrap-MS/MS experiments
were carried out in order to select and submit these ions
to fragmentation experiments using the parameters previ-
ously chosen by ESI-MS and ESI-MS/MS direct infusion
experiments. Bymatching experimental MS/MS spectra with
those reported in literature and/or with those reported in
a public repository of mass spectral data called MassBank
[35], compounds 1–16 were identified, with the exception of
compounds 3, 5, and 8 (unknown compounds).
Table 5 reports identification of compounds, based on
high resolution mass spectrometric data, chemical for-
mula derived by accurate mass maturation, retention times,
MS/MS results, and references used for identification. Com-
pounds 1 and 2 were identified by the diagnostic [M −
H]− ion shown in HR ESI-MS analysis, compared with
BioMed Research International 7
Table 3: Antimicrobial activity of E. characias aqueous (a) and ethanol (b) extracts. MIC and MBC/MFC values are expressed in 𝜇g/mL.
(a)
Target microorganisms Leaves Stems Flowers
MIC MBC/MFC MIC MBC/MFC MIC MBC/MFC
E. coli >5000 — >5000 — >5000 —
S. typhimurium >5000 — >5000 — >5000 —
S. aureus 5000 >5000 >5000 — 5000 >5000
B. cereus 1250 1250 5000 >5000 2500 5000
L. monocytogenes 2500 2500 >5000 — 2500 >5000
C. albicans >5000 — >5000 — >5000 —
S. cerevisiae >5000 — >5000 — >5000 —
A. flavus >5000 >5000 >5000 — >5000 >5000
P. chrysogenum >5000 >5000 >5000 — >5000 >5000
(b)
Target microorganisms Leaves Stems Flowers
MIC MBC/MFC MIC MBC/MFC MIC MBC/MFC
E. coli >5000 — >5000 — >5000 —
S. typhimurium >5000 — >5000 — >5000 —
S. aureus 1250 2500 5000 >5000 5000 >5000
B. cereus 312.5 312.5 5000 >5000 1250 2500
L. monocytogenes 1250 1250 5000 >5000 5000 >5000
C. albicans >5000 — >5000 — >5000 —
S. cerevisiae >5000 — >5000 — >5000 —
A. flavus >5000 — >5000 — >5000 >5000
P. chrysogenum >5000 — >5000 — >5000 >5000
Positive controls: ampicillin MICs (S. aureus ATCC 6538: 2.5𝜇g/mL, B. cereus ATCC 11778: 10𝜇g/mL, and L. monocytogenes ATCC 19115: 2.5𝜇g/mL);
gentamicinMICs (E. coliATCC 35150: 10𝜇g/mL, S. typhimuriumATCC 14028: 10 𝜇g/mL); ketoconazoleMICs (C. albicansATCC 10231: 2.5𝜇g/mL, S. cerevisiae
ATCC 2601: 2.5 𝜇g/mL); amphotericin B MICs (A. flavus ATCC 46283 and P. chrysogenum ATCC 10135: 5 𝜇g/mL).
Table 4: Effects of E. characias extracts on HIV-1 RT-associated
functions.
Extracts
IC
50
(𝜇g/mL)∗
HIV-1 HIV-1
RDDP RNase H
Leaves Aqueous 0.785 ± 0.003
c 1.95 ± 1.03a,b
Ethanolic 0.75 ± 0.028c 0.685 ± 0.155b,c
Stems Aqueous 6.87 ± 0.81
a 2.235 ± 0.245a
Ethanolic 3.05 ± 0.2b 1.615 ± 0.035a,b,c
Flowers Aqueous 1.03 ± 0.0
c 1.51 ± 0.53a,b,c
Ethanolic 0.26 ± 0.08c 0.33 ± 0.1c
Efavirenz 0.0016 ± 0.0003∗∗ ND∗∗∗
RDS1759 ND 7.1 ± 0.5∗∗
∗Extracts concentration required to inhibit HIV-1 RT-associated functions
by 50%.
∗∗Values expressed in 𝜇M concentration.
∗∗∗Not done.
Means followed by distinct letters in the same column are significantly
different (𝑝 < 0.05).
standards and literature, and from the MS/MS data obtained
working in LC-ESI-Orbitrap-MS/MS in Product Ion Scan
in negative ion mode, and the compounds were identified
by MassBank as gallic acid and catechin and confirmed
by standard analysis. Compounds 7, 9, 10, 11, and 15 were
identified by the diagnostic [M −H]− ions shown in HR ESI-
MS analysis, their fragmentation profiles obtained in LC-ESI-
(Orbitrap)-MS/MS in Product Ion Scan in negative ionmode,
compared with literature data, and resulting compounds
previously reported in E. characias leaves [25]. They are
derivatives of quercetin. Compounds 4 and 6were tentatively
identified by the diagnostic [M − H]− ions shown in HR
ESI-MS analysis, their fragmentation profiles obtained in LC-
ESI-Orbitrap-MS/MS in Product Ion Scan in negative ion
mode, compared with MassBank data. They were proposed
as myricetin derivatives. The identity of compound 12 was
hypothesized from the MSMS data obtained working in
LC-ESI-Orbitrap-MS/MS in Product Ion Scan in negative
ion mode, and the compound was tentatively identified by
MassBank, as dicaffeoylquinic acid. Compounds 13 and 14
were tentatively identified by the diagnostic [M − H]− ion
shown in HR ESI-MS analysis and from the MS/MS data
obtained working in LC-ESI-Orbitrap-MS/MS in Product
Ion Scan in negative ion mode, compared with literature.
These compounds were not described in E. characias, but in
another plant of the same genus, Euphorbia pekinensis [36].
From a quantitative point of view, the most significant
polyphenolic compounds were flavonoids, mainly quercetin
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Figure 4: Identification of polyphenolic compounds in E. characias leaves using LC-ESI-Orbitrap-MS/MS in negative ion mode.
Chromatographic conditions are described in the text. A list of compounds is reported in Table 5.
derivatives (Table 5). Quercetin-3-(2-O-acetyl)-arabinoside
(15) and quercetin-3-O-rhamnoside (11) were themost abun-
dant compounds (39.99 ± 2.52 and 31.88 ± 2.75 g/L, resp.),
followed by quercetin-3-O-arabinoside (10) and quercetin-
3-O-xyloside (9). These findings are in agreement with the
results of previous investigations on the aerial part of E.
characias [25]. For the first time other compounds such as
gallic acid (1), catechin (2), myricetin derivatives, and ellagic
acid derivativeswere quantified inE. characias leaves extracts.
Some of these compounds such as gallic acid, catechin, and
quercetin-3-O-rhamnoside were isolated from other plant
sources and displayed cholinesterase inhibitory activity [44–
46]. Several compounds are derivatives of myricetin (4 and
6) and quercetin (7, 9–11, and 15), two flavonoids which
showed anti-HIV-1 activity [8, 47]. Finally, previous studies
indicated that quercetin derivatives possess antimicrobial
properties and the mechanisms of these compounds were
attributed to their ability to form complexeswith extracellular
and soluble proteins and bacterial cell walls [48]. This might
explain the lack of activity or the minor susceptibility of
the Gram-negative bacteria and the greater inhibition of
E. characias extract against Gram-positive bacteria. In fact,
Gram-negative bacteria possess an effective permeability bar-
rier represented by the outer lipidic membrane which could
restrict the penetration of plant extracts.The next step will be
the isolation of pure compounds of the extract and the evalua-
tion and characterization of their biological activities in order
to find new bioactive compounds from a natural source.
4. Conclusions
The results of this study indicate that E. characias aerial parts
are a good source of antioxidant, antimicrobial, antiviral,
and anti-ChE compounds. Leaves extracts exhibited the
strongest antioxidant activities and the highest amount of
polyphenols and cholinesterase inhibitors molecules, while
flowers extracts seemed to be the best sources of flavonoids
and exerted the best antiviral activity. Extracts also exhibited
acetyl- and butyrylcholinesterase inhibition and these are
promising results since ChE inhibitors represent the standard
therapeutic approach to the treatment of Alzheimer’s disease.
Analyzing all results, extraction with ethanol was more
efficient than use of plain water. In fact ethanol extracts
were found to provide the highest antioxidant and anti-
ChE activity and phenolic and flavonoids contents compared
with the correspondent aqueous extract. The same result was
found for antimicrobial assays since ethanol extracts were
found to bemore effective towards the food-borne pathogens
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Table 5: Identification of polyphenolic compounds in E. characias leaves ethanolic extract using LC-ESI-Orbitrap-MS/MS in negative ion
mode and quantification by LC-DAD.
Putative identification RT (min) g/L (mean ± SD) MW [M −H]− Molecularformula MS/MS References
1 Gallic acida 7.17 0.94 ± 0.23 170.0215 169.1195 C
7
H
6
O
5
125.02 [35]
2 Catechina 14.75 0.65 ± 0.04 290.2680 289.0715 C
15
H
13
O
6
245.05
205.04
125.02
[35]
3 Unknown 20.39 NQ 951.0734 932.70 —
4 Myricetin-hexoseb 23.16 0.02 ± 0.00 480.0904 479.0824 C
21
H
19
O
13
317.06 [35]
5 Unknown 24.56 NQ 960.789 913.01 —
6 Myricetin-deoxyhexoseb 26.49 0.01 ± 0.00 464.0954 463.0873 C
21
H
19
O
12
317.06 [35]
7 Quercetin-3-O-glucosidea 27.52 1.94 ± 0.09 464.0954 463.0873 C
21
H
19
O
12
301.07 [25]
8 Unknown 28.97 NQ 469.0516 C
22
H
13
O
12
393.07 —
9 Quercetin-3-O-xylosidec 29.20 2.25 ± 0.16 434.0849 433.0771 C
20
H
17
O
11
301.07 [25]
10 Quercetin-3-O-arabinosidec 30.18 9.54 ± 0.36 434.0849 433.0771 C
20
H
17
O
11
301.07 [25]
11 Quercetin-3-O-rhamnosidea 31.02 31.88 ± 2.75 448.1005 447.0924 C
21
H
19
O
11
301.25 [25]
12 Di-O-caffeoylquinic acidd 31.07 0.02 ± 0.00 516.0962 515.0800 C
17
H
23
O
18
353.10
191.02 [35]
13 3,3󸀠-Dimethyl ellagic acid pentosee 31.53 0.01 ± 0.00 462.0798 461.0877 C
22
H
19
O
12
329.02 [36]
14 3,3󸀠-Dimethyl ellagic acid deoxyhexosee 35.70 0.01 ± 0.00 476.0954 475.0877 C
22
H
19
O
12
329.02 [36]
15 Quercetin-3-(2-O-acetyl)-arabinosidea 35.74 39.99 ± 2.52 476.0954 475.0877 C
22
H
19
O
12
300.08 [25]
16 Acacetin glucuronidef 39.84 0.50 ± 0.02 460.1005 459.0923 C
22
H
19
O
11
283.27 [35]
aQuantified using corresponding authentic standard; bquantified as equivalent of myricetin-3-O-glucoside; cquantified as equivalent of quercetin-3-O-
glucoside; dquantified as equivalent of chlorogenic acid; equantified as equivalent of ellagic acid; fquantified as equivalent of acacetin; NQ: not quantified.
L. monocytogenes, S. aureus, and B. cereus. HPLC-DAD and
LC-ESI-MS chromatogram revealed that leaves ethanolic
extract showed the presence of several phenolic and flavonoid
compounds known for their antioxidant activity and that
could be responsible for the biological activity of the extract.
Further studies will be performed for the isolation and
characterization of single active compounds, which could be
used for pharmaceutical application as well as in food system
for the prevention of the growth of food-borne bacteria.
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